Skip to main content
Top
Published in: Emergency Radiology 2/2004

01-12-2004 | Review Article

Advanced imaging application for acute ischemic stroke

Authors: Jeffrey Farkas, Andrew Xavier, Charles J. Prestigiacomo

Published in: Emergency Radiology | Issue 2/2004

Login to get access

Abstract

With the approval of intravenous recombinant tissue plasminogen activator (r-TPA) in 1995, acute ischemic stroke therapy is increasingly being administered. Currently the approach to imaging these patients is very simplistic. Typically, noncontrast head computed tomography (CT) is the only study performed prior to treatment. Advanced imaging using CT or magnetic resonance imaging (MRI) can play a very important role in the triage and classification of patients with acute ischemic stroke. With knowledge of the location and size of the occlusion as well as the collateral circulation, the best treatment can be selected, minimizing any morbidity from treatment and maximizing the chance of success. The identification and stratification of patients according to their imaging and clinical features will further individualize treatment and allow tailored therapy. This review will discuss rapid imaging techniques that are easily available and the rationale for their use.
Appendix
Available only for authorised users
Literature
1.
go back to reference 2001 Heart and Stroke Statistical Update (2002) American Stroke Association, Dallas, pp 1–8 2001 Heart and Stroke Statistical Update (2002) American Stroke Association, Dallas, pp 1–8
2.
go back to reference del Zoppo GJ, et al (1992) Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 32:78–86PubMed del Zoppo GJ, et al (1992) Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 32:78–86PubMed
3.
go back to reference Jones TH, et al (1981) Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg 54:773–782PubMed Jones TH, et al (1981) Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg 54:773–782PubMed
4.
go back to reference Zivin JA, et al (1985) Tissue plasminogen activator reduces neurological damage after cerebral embolism. Science 230:1289–1292PubMed Zivin JA, et al (1985) Tissue plasminogen activator reduces neurological damage after cerebral embolism. Science 230:1289–1292PubMed
5.
go back to reference Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995 333:1581–1587 Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995 333:1581–1587
6.
go back to reference Albers GW, et al (2002) ATLANTIS trial: results for patients treated within 3 hours of stroke onset. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. Stroke 33:493–495CrossRefPubMed Albers GW, et al (2002) ATLANTIS trial: results for patients treated within 3 hours of stroke onset. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. Stroke 33:493–495CrossRefPubMed
7.
go back to reference Albers GW, et al (2000) Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 283:1145–1150CrossRefPubMed Albers GW, et al (2000) Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 283:1145–1150CrossRefPubMed
8.
go back to reference Clark WM, et al (1999) Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 282:2019–2026CrossRefPubMed Clark WM, et al (1999) Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 282:2019–2026CrossRefPubMed
9.
go back to reference Hacke W, et al (1998) Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European–Australasian Acute Stroke Study Investigators. Lancet 352:1245–1251CrossRefPubMed Hacke W, et al (1998) Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European–Australasian Acute Stroke Study Investigators. Lancet 352:1245–1251CrossRefPubMed
10.
go back to reference del Zoppo GJ, et al (1998) PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 29:4–11PubMed del Zoppo GJ, et al (1998) PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 29:4–11PubMed
11.
go back to reference Furlan A, et al (1999) Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 282:2003–2011CrossRefPubMed Furlan A, et al (1999) Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 282:2003–2011CrossRefPubMed
12.
go back to reference Katzan IL, et al (2000) Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA 283:1151–1158CrossRefPubMed Katzan IL, et al (2000) Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA 283:1151–1158CrossRefPubMed
13.
go back to reference Chiu D, et al (1998) Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. Stroke 29:18–22PubMed Chiu D, et al (1998) Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. Stroke 29:18–22PubMed
14.
go back to reference Morgenstern LB, et al (2002) Improving delivery of acute stroke therapy: The TLL Temple Foundation Stroke Project. Stroke 33:160–166CrossRefPubMed Morgenstern LB, et al (2002) Improving delivery of acute stroke therapy: The TLL Temple Foundation Stroke Project. Stroke 33:160–166CrossRefPubMed
15.
go back to reference Christou I, et al (2000) Timing of recanalization after tissue plasminogen activator therapy determined by transcranial Doppler correlates with clinical recovery from ischemic stroke. Stroke 31:1812–1816PubMed Christou I, et al (2000) Timing of recanalization after tissue plasminogen activator therapy determined by transcranial Doppler correlates with clinical recovery from ischemic stroke. Stroke 31:1812–1816PubMed
16.
go back to reference von Kummer R, et al (1997) Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology 205:327–333PubMed von Kummer R, et al (1997) Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology 205:327–333PubMed
17.
go back to reference Bryan RN, et al (1991) Diagnosis of acute cerebral infarction: comparison of CT and MR imaging. AJNR Am J Neuroradiol 12:611–620PubMed Bryan RN, et al (1991) Diagnosis of acute cerebral infarction: comparison of CT and MR imaging. AJNR Am J Neuroradiol 12:611–620PubMed
18.
go back to reference Truwit CL, et al (1990) Loss of the insular ribbon: another early CT sign of acute middle cerebral artery infarction. Radiology 176:801-806PubMed Truwit CL, et al (1990) Loss of the insular ribbon: another early CT sign of acute middle cerebral artery infarction. Radiology 176:801-806PubMed
19.
go back to reference Tomura N, et al (1988) Early CT finding in cerebral infarction: obscuration of the lentiform nucleus. Radiology 168:463–467PubMed Tomura N, et al (1988) Early CT finding in cerebral infarction: obscuration of the lentiform nucleus. Radiology 168:463–467PubMed
21.
go back to reference Lev MH, et al (1999) Acute stroke: improved nonenhanced CT detection—benefits of soft-copy interpretation by using variable window width and center level settings. Radiology 213:150–155PubMed Lev MH, et al (1999) Acute stroke: improved nonenhanced CT detection—benefits of soft-copy interpretation by using variable window width and center level settings. Radiology 213:150–155PubMed
22.
go back to reference Barber PA, et al (2001) Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology 56:1015–1020PubMed Barber PA, et al (2001) Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology 56:1015–1020PubMed
23.
go back to reference Hamberg LM, et al (1996) Quantitative high-resolution measurement of cerebrovascular physiology with slip-ring CT. AJNR Am J Neuroradiol 17:639–650PubMed Hamberg LM, et al (1996) Quantitative high-resolution measurement of cerebrovascular physiology with slip-ring CT. AJNR Am J Neuroradiol 17:639–650PubMed
24.
go back to reference Hunter GJ, et al (1998) Assessment of cerebral perfusion and arterial anatomy in hyperacute stroke with three-dimensional functional CT: early clinical results. AJNR Am J Neuroradiol 19:29–37PubMed Hunter GJ, et al (1998) Assessment of cerebral perfusion and arterial anatomy in hyperacute stroke with three-dimensional functional CT: early clinical results. AJNR Am J Neuroradiol 19:29–37PubMed
25.
go back to reference Ringleb PA, et al (2002) Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke: useful or harmful? Stroke 33:1437–1441CrossRefPubMed Ringleb PA, et al (2002) Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke: useful or harmful? Stroke 33:1437–1441CrossRefPubMed
26.
go back to reference Kent DM, R Ruthazer and HP Selker (2003) Are some patients likely to benefit from recombinant tissue-type plasminogen activator for acute ischemic stroke even beyond 3 hours from symptom onset? Stroke 34:464–467CrossRefPubMed Kent DM, R Ruthazer and HP Selker (2003) Are some patients likely to benefit from recombinant tissue-type plasminogen activator for acute ischemic stroke even beyond 3 hours from symptom onset? Stroke 34:464–467CrossRefPubMed
27.
go back to reference Lev MH, et al (2001) CT angiography in the rapid triage of patients with hyperacute stroke to intraarterial thrombolysis: accuracy in the detection of large vessel thrombus. J Comput Assist Tomogr 25:520–528CrossRefPubMed Lev MH, et al (2001) CT angiography in the rapid triage of patients with hyperacute stroke to intraarterial thrombolysis: accuracy in the detection of large vessel thrombus. J Comput Assist Tomogr 25:520–528CrossRefPubMed
28.
go back to reference Christou I, et al (2002) Intravenous tissue plasminogen activator and flow improvement in acute ischemic stroke patients with internal carotid artery occlusion. J Neuroimaging 12:119–123PubMed Christou I, et al (2002) Intravenous tissue plasminogen activator and flow improvement in acute ischemic stroke patients with internal carotid artery occlusion. J Neuroimaging 12:119–123PubMed
29.
go back to reference Libman RB, et al (1995) Conditions that mimic stroke in the emergency department. Implications for acute stroke trials. Arch Neurol 52:1119–1122PubMed Libman RB, et al (1995) Conditions that mimic stroke in the emergency department. Implications for acute stroke trials. Arch Neurol 52:1119–1122PubMed
Metadata
Title
Advanced imaging application for acute ischemic stroke
Authors
Jeffrey Farkas
Andrew Xavier
Charles J. Prestigiacomo
Publication date
01-12-2004
Publisher
Springer-Verlag
Published in
Emergency Radiology / Issue 2/2004
Print ISSN: 1070-3004
Electronic ISSN: 1438-1435
DOI
https://doi.org/10.1007/s10140-004-0347-2

Other articles of this Issue 2/2004

Emergency Radiology 2/2004 Go to the issue